BIOTRONIK Celebrates Successful Partnership with HBI on the Occasion of its 30th Anniversary
The Innovative Medical Device Manufacturer Marks Thirty Years of HBI's Lifesaving Efforts with a Special Donation
According to the World Health Organization (WHO), an estimated 17 million people worldwide die of cardiovascular disease each year, making it the number one cause of death among low and middle income populations.1 In order to combat these numbers, BIOTRONIK formed a special partnership with HBI in 2010, donating more than 5,600 life-saving devices so far.
Since its inception in 1963, BIOTRONIK has been committed to saving lives and improving quality of life. Serving the community and helping those in need is more than a corporate responsibility, it is one of the truest reflections of the company motto, "excellence for life." A global leader in donating devices to economically disadvantaged patients, HBI works to combat cardiovascular disease worldwide.
"As a company known for our dedication to patient health, we are proud to give patients in need access to life-saving, high-quality care in partnership with this groundbreaking charitable organization," said Wolf Ruhnke, Vice President at BIOTRONIK. "As a company that celebrated its own 50th anniversary only last year, we congratulate HBI on its first 30 years of success!"
"Back in 2010, when we first formed a partnership with BIOTRONIK, we were thrilled to be able to create ties with such a reputable device manufacturer, capable of making such a difference," commented HBI Chairman and CEO Dr. Benedict S. Maniscalco. "Today, we can say that that partnership has had a profound effect on the number of lives we've been able to save. We hope to save many more, and we know that with BIOTRONIK's help, we will."
For more information, visit: www.biotronik.com
One of the world's leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; the world's first 4 F-compatible 200 mm peripheral stent; Orsiro, the industry's first hybrid drug-eluting stent; and the world's first implantable cardioverter defibrillators and heart failure therapy devices with ProMRI® technology. As a company with global reach, BIOTRONIK is proud to take on the social responsibility of giving aid to those in need around the world, as well as overseeing global training and educational opportunities.
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
Neues Jobprofil, neue Ausbildung – KI-Manager
68 Prozent der Deutschen möchten KI selbst erleben – so eine Studie im Auftrag des Digitalverbandes Bitkom. Viele erleben KI bereits, ohne es vielleicht zu wissen: Sprachassistenten wie Alexa oder Siri setzten auf diese Technologie. Und demnächst kann man sich sogar zum KI-Manager ausbilden lassen.Weiterlesen